Aceclofenac injections 150 mg

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]. It belongs to gemifloxacin intermediates products category. Contact us for more inf...

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abacavir sulphate. It belongs to antiretroviral apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abiraterone. It belongs to anticancer apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac. It belongs to antiinflammatory ( nsaid ) apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac sustained release tablets 200 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac tablets 100 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes acyclovir. It belongs to lypholised powder ready to fill category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adapalene. It belongs to antiacne apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adapalene and clindamycin gel (0.1 + 1) % w/w. It belobgs to dermotology finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adefovir. It belongs to antiretroviral apis category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.